These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6163756)
1. Integration of chemotherapy into a combined modality treatment plan for head and neck cancer: a review. Glick JH; Taylor SG Int J Radiat Oncol Biol Phys; 1981 Feb; 7(2):229-42. PubMed ID: 6163756 [No Abstract] [Full Text] [Related]
2. Combined chemotherapy, radiotherapy, and surgery in the treatment of advanced but localized solid malignant tumours. Stephens FO Aust N Z J Surg; 1974 Nov; 44(4):343-53. PubMed ID: 4143104 [No Abstract] [Full Text] [Related]
3. Preoperative chemo-radiotherapy in advanced head and neck cancer. Pearlman NW; Meyers AD; Johnson FB; DiBella NJ Head Neck Surg; 1982; 5(1):10-4. PubMed ID: 6184328 [TBL] [Abstract][Full Text] [Related]
4. Hyperthermia as an adjuvant to radiation- and/or chemotherapy in far advanced recurrences of the head and neck region. Steindorfer P; Jakse R; Germann R; Schneider G; Berger A; Mischinger HJ; Rehak P Strahlenther Onkol; 1987 Jul; 163(7):449-52. PubMed ID: 2441480 [No Abstract] [Full Text] [Related]
5. Combination chemotherapy used prior to radiation therapy for locally advanced squamous cell carcinoma of the head and neck. Tannock I; Cummings B; Sorrenti V Cancer Treat Rep; 1982 Jun; 66(6):1421-4. PubMed ID: 6177413 [TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy for advanced squamous cell carcinoma of the head and neck. Coker DD; Elias EG; Chretien PB; Gray WC; Coleman JJ; Zentai TA; Didolkar MS; Morris DM; Viravathana T; Hebel JR Head Neck Surg; 1981; 4(2):111-7. PubMed ID: 6171545 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck: Preliminary assessment of an intensive drug regimen. Elias EG; Chretien PB; Monnard E; Khan T; Bouchelle WH; Wiernik PH; Lipson SD; Hande KR; Zentai T Cancer; 1979 Mar; 43(3):1025-31. PubMed ID: 85477 [No Abstract] [Full Text] [Related]
8. Randomized neo-adjuvant chemotherapy trial for advanced head and neck cancer. Stolwijk C; Wagener DJ; Van den Broek P; Levendag PC; Kazem I; Bruaset I; De Mulder PH Neth J Med; 1985; 28(9):347-51. PubMed ID: 2413379 [No Abstract] [Full Text] [Related]
9. [Treatment for recurrent head and neck carcinomas]. Tsukuda M Gan To Kagaku Ryoho; 1998 Feb; 25(3):303-8. PubMed ID: 9492820 [TBL] [Abstract][Full Text] [Related]
10. A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck. Drelichman A; Cummings G; Al-Sarraf M Cancer; 1983 Aug; 52(3):399-403. PubMed ID: 6190548 [TBL] [Abstract][Full Text] [Related]
11. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. Ervin TJ; Clark JR; Weichselbaum RR; Fallon BG; Miller D; Fabian RL; Posner MR; Norris CM; Tuttle SA; Schoenfeld DA J Clin Oncol; 1987 Jan; 5(1):10-20. PubMed ID: 2433406 [TBL] [Abstract][Full Text] [Related]
12. A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer. Vogl SE; Schoenfeld DA; Kaplan BH; Lerner HJ; Engstrom PF; Horton J Cancer; 1985 Aug; 56(3):432-42. PubMed ID: 2408735 [TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck. Clavel M; Cognetti F; Dodion P; Wildiers J; Rosso R; Rossi A; Gignoux B; Van Rymenant M; Cortes-Funes H; Dalesio O Cancer; 1987 Sep; 60(6):1173-7. PubMed ID: 2441836 [TBL] [Abstract][Full Text] [Related]
14. Analysis of treatment failure patterns. A Southwest Oncology Group Study. Schuller DE; Stein DW; Metch B Arch Otolaryngol Head Neck Surg; 1989 Jul; 115(7):834-6. PubMed ID: 2472157 [TBL] [Abstract][Full Text] [Related]
15. A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study. Jacobs C; Meyers F; Hendrickson C; Kohler M; Carter S Cancer; 1983 Nov; 52(9):1563-9. PubMed ID: 6352004 [TBL] [Abstract][Full Text] [Related]
16. Cis-dichlorodiammineplatinum(II), methotrexate, bleomycin, and vincristine in head and neck cancer: a pilot study. King GW; Halpin JJ; Smith RE; Batley F; Schuller DE Cancer Treat Rep; 1979; 63(11-12):1735-8. PubMed ID: 93508 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of squamous cell cancer of the head and neck. Gill PG; Hains JD; Iyer P; Rozenbilds JG; Ahmad A; Abbott RL; David DJ; Ward GG; Brown MW; Harvey ND Med J Aust; 1983 May; 1(10):463-6. PubMed ID: 6188946 [TBL] [Abstract][Full Text] [Related]
18. Survival after "palliative" cytotoxic chemotherapy for head-and-neck cancer. Stell PM; Morton RP; Campbell IT; Wilson JA Lancet; 1983 Nov; 2(8360):1205. PubMed ID: 6196584 [No Abstract] [Full Text] [Related]
19. Alternating regimens in recurrent and metastatic squamous cell carcinoma of the head and neck. Cognetti F; Molinari A; Carlini P; Frassineti GL; PinnarĂ² P; Marangolo M Oncology; 1987; 44(5):270-2. PubMed ID: 2444912 [TBL] [Abstract][Full Text] [Related]
20. Induction redux: once more with taxanes. Adelstein DJ J Clin Oncol; 2005 Dec; 23(34):8556-8. PubMed ID: 16275933 [No Abstract] [Full Text] [Related] [Next] [New Search]